CLINICAL TRIALS PROFILE FOR CUTAQUIG
✉ Email this page to a colleague
All Clinical Trials for CUTAQUIG
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03939533 ↗ | Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases | Active, not recruiting | Octapharma | Phase 3 | 2019-10-17 | CLINICAL PHASE 3 STUDY TO MONITOR THE SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (CUTAQUIG®) ADMINISTERED AT MODIFIED DOSING REGIMENS IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CUTAQUIG
Condition Name
Clinical Trial Locations for CUTAQUIG
Trials by Country
Clinical Trial Progress for CUTAQUIG
Clinical Trial Phase
Clinical Trial Sponsors for CUTAQUIG
Sponsor Name